Similar articles for PMID: 32513905

Year	Number of Results
2002	1
2005	1
2006	2
2007	1
2008	3
2009	1
2010	6
2011	6
2012	10
2013	11
2014	11
2015	17
2016	11
2017	12
2018	11
2019	15
2020	27
2021	20

1

Monitoring Response to Transarterial Chemoembolization in Hepatocellular Carcinoma Using ¹⁸F-Fluorothymidine PET.

Sharma R, Inglese M, Dubash S, Lu H, Pinato DJ, Sanghera C, Patel N, Chung A, Tait PD, Mauri F, Crum WR, Barwick TD, Aboagye EO. Sharma R, et al. J Nucl Med. 2020 Dec;61(12):1743-1748. doi: 10.2967/jnumed.119.240598. Epub 2020 Jun 8. J Nucl Med. 2020. PMID: 32513905 Clinical Trial.

2

Imaging of proliferation in hepatocellular carcinoma with the in vivo marker 18F-fluorothymidine.

Eckel F, Herrmann K, Schmidt S, Hillerer C, Wieder HA, Krause BJ, Schuster T, Langer R, Wester HJ, Schmid RM, Schwaiger M, Buck AK. Eckel F, et al. J Nucl Med. 2009 Sep;50(9):1441-7. doi: 10.2967/jnumed.109.065896. Epub 2009 Aug 18. J Nucl Med. 2009. PMID: 19690030 Free article.

3

The value of [¹¹C]-acetate PET and [¹⁸F]-FDG PET in hepatocellular carcinoma before and after treatment with transarterial chemoembolization and bevacizumab.

Li S, Peck-Radosavljevic M, Ubl P, Wadsak W, Mitterhauser M, Rainer E, Pinter M, Wang H, Nanoff C, Kaczirek K, Haug A, Hacker M. Li S, et al. Eur J Nucl Med Mol Imaging. 2017 Sep;44(10):1732-1741. doi: 10.1007/s00259-017-3724-2. Epub 2017 May 29. Eur J Nucl Med Mol Imaging. 2017. PMID: 28555333 Free PMC article.

4

The prognostic value of 18F-FDG PET/CT for hepatocellular carcinoma treated with transarterial chemoembolization (TACE).

Ma W, Jia J, Wang S, Bai W, Yi J, Bai M, Quan Z, Yin Z, Fan D, Wang J, Han G. Ma W, et al. Theranostics. 2014 May 1;4(7):736-44. doi: 10.7150/thno.8725. eCollection 2014. Theranostics. 2014. PMID: 24883123 Free PMC article.

5

11C-acetate and 18F-fluorodeoxyglucose positron emission tomography/computed tomography dual imaging for the prediction of response and prognosis after transarterial chemoembolization.

Park S, Kim TS, Kang SH, Kim HB, Park JW, Kim SK. Park S, et al. Medicine (Baltimore). 2018 Sep;97(37):e12311. doi: 10.1097/MD.0000000000012311. Medicine (Baltimore). 2018. PMID: 30212970 Free PMC article.

6

Imaging of cellular proliferation in liver metastasis by [18F]fluorothymidine positron emission tomography: effect of therapy.

Contractor K, Challapalli A, Tomasi G, Rosso L, Wasan H, Stebbing J, Kenny L, Mangar S, Riddle P, Palmieri C, Al-Nahhas A, Sharma R, Turkheimer F, Coombes RC, Aboagye E. Contractor K, et al. Phys Med Biol. 2012 Jun 7;57(11):3419-33. doi: 10.1088/0031-9155/57/11/3419. Epub 2012 May 10. Phys Med Biol. 2012. PMID: 22572708 Clinical Trial.

7

Computed tomography perfusion in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma.

Chen G, Ma DQ, He W, Zhang BF, Zhao LQ. Chen G, et al. World J Gastroenterol. 2008 Oct 7;14(37):5738-43. doi: 10.3748/wjg.14.5738. World J Gastroenterol. 2008. PMID: 18837093 Free PMC article.

8

Use of contrast-enhanced ultrasonography with a perflubutane-based contrast agent performed one day after transarterial chemoembolization for the early assessment of residual viable hepatocellular carcinoma.

Takizawa K, Numata K, Morimoto M, Kondo M, Nozaki A, Moriya S, Ishii T, Oshima T, Fukuda H, Okada M, Takebayashi S, Maeda S, Tanaka K. Takizawa K, et al. Eur J Radiol. 2013 Sep;82(9):1471-80. doi: 10.1016/j.ejrad.2013.04.045. Epub 2013 Jun 13. Eur J Radiol. 2013. PMID: 23769188 Clinical Trial.

9

Comparison of volume perfusion computed tomography and contrast-enhanced ultrasound for assessment of therapeutic effect of transarterial chemoembolization in patients with hepatocellular carcinoma: a preliminary report.

Kaufmann S, Schulze M, Spira D, Horger M. Kaufmann S, et al. Acta Radiol. 2016 Jan;57(1):8-12. doi: 10.1177/0284185114566442. Epub 2015 Jan 13. Acta Radiol. 2016. PMID: 25585848

10

Prognostic Value of 18-Fluorodeoxyglucose-Positron Emission Tomography After Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma Undergoing Orthotopic Liver Transplantation.

Cascales-Campos PA, Ramírez P, Lopez V, Gonzalez R, Saenz-Mateos L, Llacer E, Sánchez Bueno F, Robles R, Pons JA, Capel A, Frutos L, Navarro JL, Muñoz-Ramon P, Parrilla P. Cascales-Campos PA, et al. Transplant Proc. 2015 Oct;47(8):2374-6. doi: 10.1016/j.transproceed.2015.08.026. Transplant Proc. 2015. PMID: 26518931

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed